Bank of Montreal’s Lisata Therapeutics LSTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-133
Closed -$3K 4388
2021
Q1
$3K Buy
+133
New +$4.03K ﹤0.01% 4826
2017
Q4
Sell
-7
Closed 4258
2017
Q3
$0 Hold
7
﹤0.01% 4256
2017
Q2
$0 Hold
7
﹤0.01% 4224
2017
Q1
$1K Hold
7
﹤0.01% 3892
2016
Q4
$0 Hold
7
﹤0.01% 4134
2016
Q3
$0 Hold
7
﹤0.01% 4116
2016
Q2
$1K Hold
7
﹤0.01% 3986
2016
Q1
$1K Hold
7
﹤0.01% 4077
2015
Q4
$1K Hold
7
﹤0.01% 4096
2015
Q3
$2K Buy
+7
New +$1.76K ﹤0.01% 3803
2015
Q2
Sell
-1
Closed 4041
2015
Q1
$0 Hold
1
﹤0.01% 4109
2014
Q4
$0 Buy
+1
New +$681 ﹤0.01% 4105

Other funds holding LSTA

Bank of Montreal's LSTA Position: Q2 2021 in Review

Bank of Montreal sold out of Lisata Therapeutics (LSTA) in Q2 2021, closing a stake of 133 shares — an estimated $3K sold.

Bank of Montreal first reported a position in LSTA in Q4 2014 and held it in 12 quarters. The position peaked at $3K in Q1 2021. 27 funds tracked by Wall St. Rank hold LSTA as of Q2 2021.

  • Bank of Montreal reported no remaining Lisata Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 133 Lisata Therapeutics shares in Q2 2021, an estimated $3K.
  • Bank of Montreal first reported a position in Lisata Therapeutics in Q4 2014 and held it in 12 quarters.
  • Bank of Montreal's Lisata Therapeutics position peaked at $3K in Q1 2021.
  • 27 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.